Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
about
Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression.Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers.Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?Use of hepatitis B core antibody-positive donors for liver transplantation.Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers.Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool.Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantationRisk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis.Update on donor-derived infections in liver transplantation.Risks and treatment strategies for de novo hepatitis B virus infection from anti-HBc-positive donors in pediatric living donor liver transplantation.Active immunization to prevent de novo hepatitis B virus infection in pediatric live donor liver recipients.Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.Case report of lamivudine-resistant hepatitis B virus infection post liver transplantation from a hepatitis B core antibody donor.Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
P2860
Q30434625-F1FA38CD-B929-42A1-9829-0F3C0A174F11Q34365421-09AE1DE6-B533-43F8-A65F-E6517709E5B5Q34917705-ABFBFB75-58E2-411E-B8B1-C4569274CAE5Q34936283-1DA9005A-B6BE-401B-9B65-5C8C8EABA0FEQ34959703-5B9A4E8A-5BCD-48C8-AF35-91E68466A1ECQ35180107-7D48C067-C583-4291-8318-48BF41267AF9Q35715908-7EECB36D-D524-4DB4-B467-7BE9E489D2D2Q36909187-C63F8267-EC2A-4689-B72A-25CFC7782F80Q37842669-6C4B3613-7CA9-4BDB-8C6B-1E91CB1936B8Q38092789-29FB3E8F-0FBA-40F0-A4EA-97115FE14065Q39116834-821C33E3-9113-4A99-8DB7-B8678F07F769Q45408268-71977572-4AC1-4B11-9B7A-F9FFCEAC6722Q45414817-82A4DB25-2FCA-44B3-A577-389685ED582FQ45417753-BB0F24F5-DC16-4686-8310-5E731AC9850FQ45421748-7108F10A-6848-4D6D-97ED-73409426DA08
P2860
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
@en
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
@nl
type
label
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
@en
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
@nl
prefLabel
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
@en
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
@nl
P2093
P1433
P1476
Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.
@en
P2093
David Holt
David Van Thiel
John J Brems
Ryan Thomas
P304
572-5; discussion 575-6
P356
10.1001/ARCHSURG.137.5.572
P577
2002-05-01T00:00:00Z